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Hemodynamic forces play an essential epigenetic
role in heart valve development, but how they do so
is not known. Here, we show that the shear-respon-
sive transcription factor KLF2 is required in endocar-
dial cells to regulate themesenchymal cell responses
that remodel cardiac cushions to mature valves.
Endocardial Klf2 deficiency results in defective valve
formation associated with loss of Wnt9b expression
and reduced canonical WNT signaling in neighboring
mesenchymal cells, a phenotype reproduced by
endocardial-specific loss ofWnt9b. Studies in zebra-
fish embryos reveal that wnt9b expression is simi-
larly restricted to the endocardial cells overlying the
developing heart valves and is dependent upon
both hemodynamic shear forces and klf2a expres-
sion. These studies identify KLF2-WNT9B signaling
as a conserved molecular mechanism by which fluid
forces sensed by endothelial cells direct the complex
cellular process of heart valve development and sug-
gest that congenital valve defects may arise due to
subtle defects in thismechanotransduction pathway.
INTRODUCTION
Heart valves ensure that the beating heart drives unidirectional
blood flow. Valve function must be mechanically flawless, as
the heart beats continuously and either obstruction of forward
flow or backward regurgitation of blood due to a defective valve
can result in heart failure. Heart valve defects are among the
most common human congenital anomalies, with an incidence
of approximately 2% of live births (Hoffman and Kaplan, 2002).DeveAlthough some valvular heart defects have been linked to
specific genetic mutations (e.g., in NOTCH1, TBX5, GATA4,
TBX20, LMCD1, TNS1, and DCHS1) (Dina et al., 2015; Durst
et al., 2015; Garg et al., 2005; Richards and Garg, 2010; Theodo-
ris et al., 2015), the majority have no clearly definable genetic or
environmental cause (Levine et al., 2015). Thus, it is thought that
epigenetic factors play an important role in the pathogenesis of
congenital valve defects.
Heart valve development in the mouse begins at E9.5–10.5
with the formation of cardiac cushions at the sites of future
atrioventricular (AV) and outflow tract (OFT) valves (Gitler
et al., 2003; MacGrogan et al., 2014). Cushion formation begins
with endocardial-mesenchymal transformation (EMT), a pro-
cess in which endocardial cells delaminate from an organized
cell layer, transform into mesenchymal cells, and invade the
matrix that separates the endocardial andmyocardial cell layers
(Markwald et al., 1977). In addition to their contribution to future
valves, cardiac cushions also form the membranous septum
and basal parts of the aortic and pulmonic outflow tracts.
Following completion of EMT, the bulky cardiac cushions are
gradually remodeled to mature valves with thin, perfectly
co-apting leaflets (MacGrogan et al., 2014). Although the pro-
cesses of EMT and cushion formation have been elucidated in
significant molecular and cellular detail (reviewed in von Gise
and Pu, 2012), the mechanisms that underlie subsequent re-
modeling to mature valves remain poorly understood. Since
genetically modified mice with defects in EMT rarely survive
to birth, it is likely that most human congenital heart valve de-
fects reflect defects in cushion remodeling rather than cushion
formation.
Early studies of heart development in the chick embryo noted
that the future outflow tracts of the heart formed along lines
defined by visibly distinct streams of blood (Jaffee, 1965),
suggesting that blood flowmay be an important epigenetic regu-
lator of heart development. Direct evidence for this hypothesis
has come from studies in both chick and zebrafish embryos inlopmental Cell 43, 1–16, November 6, 2017 ª 2017 Elsevier Inc. 1
Figure 1. Graded Expression of KLF2 and KLF4 in the Endocardial Cells of the Remodeling Cardiac Cushions
(A) KLF2 (green) and KLF4 (red) expression in developing heart valves were detected by immunostaining GFP-KLF2 hearts at E10.5, E12.5, and E14.5 with anti-
GFP and anti-KLF4 antibodies. DAPI (blue) denotes nuclei. Scale bar represents 70mm at E10.5 and 100 mm at E12.5 and E14.5.
(B) Representative images showing how endocardial cell GFP-KLF2 (green) intensity along the cushion endocardium was calculated. White dotted lines indicate
the relative positions of endocardial cells measured in pixels. Scale bar represents 100 mm.
(C) Representative plots showing endocardial GFP-KLF2 intensity across the OFT and AV cushions shown in (B).
(D and E) Quantitation of variable, spatially determined GFP-KLF2 expression in the developing E12.5 valves. Representative images of OFT and AV valves
depicting how the KLF2-GFP (green) was quantified based on three defined zones as shown in (D): 1, artery/atrial side (predicted to have lower shear forces); 2,
area of valve leaflet contact (predicted to have higher shear forces); 3, ventricular side (predicted to have lower shear forces). Scale bar represents 100 mm.
(legend continued on next page)
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fects, many involving valve development and function (Hogers
et al., 1999; Hove et al., 2003; Sedmera et al., 1999; Vermot
et al., 2009; Yalcin et al., 2010). Mechanical blockade of blood
flow through the developing fish heart or alteration in fluid shear
forces achieved by changing blood viscosity or cardiac contrac-
tile function disrupt valve formation (Hove et al., 2003; Vermot
et al., 2009). Similarly, conotruncal banding or ligation of major
blood vessels leads to valve malformations and septal defects
in chick embryos (Hogers et al., 1999; Sedmera et al., 1999).
Extending these studies to mammals has been difficult, how-
ever, because lack of blood flow results in embryonic lethality
by E10 in the mouse (Wakimoto et al., 2000), a time point prior
to cushion remodeling and mature valve formation.
The molecular pathway(s) by which blood flow and hemody-
namic forces regulate heart valve development remain poorly
understood. Expression of the transcription factor KLF2 is
regulated by fluid shear in cultured human endothelial cells
ex vivo and in mouse and human vascular endothelium in vivo
(Dekker et al., 2002, 2005; Lee et al., 2006; Parmar et al.,
2005; Zhou et al., 2015). In the developing zebrafish heart,
klf2a is strongly expressed in endothelial cells overlying the
developing valve and strictly dependent upon hemodynamic
forces, and loss of klf2a confers valve defects like those
observed with loss of blood flow or shear (Heckel et al.,
2015; Steed et al., 2016; Vermot et al., 2009). Whether KLF2
plays a similar requisite role in mammalian heart development
and, more importantly, whether and how information from he-
modynamic forces sensed by endocardial cells in contact with
blood might be relayed through KLF2 to instruct underlying
cells not exposed to blood during the development of heart
valves is unknown.
In the present study, we demonstrate that KLF2 and KLF4,
related shear-responsive transcription factors (Clark et al.,
2011; McCormick et al., 2001; Zhou et al., 2015), are required
in the endocardium of the developing mouse heart during the
remodeling of cardiac cushions to mature heart valves. The
action of these endocardial transcription factors is mediated
primarily by WNT9B, a secreted protein that acts on underlying
mesenchymal cells through canonical WNT signals. Analysis of
zebrafish embryos reveals that this pathway is conserved during
fish heart valve development, and that endocardial wnt9b
expression is dependent upon hemodynamic forces and klf2a.
Our studies identify a KLF-WNT signaling axis through which
hemodynamic forces are converted by endocardial cells to
paracrine WNT signals that orchestrate the behavior of cells
not in contact with blood to form a mature heart valve. This
pathway provides an elegant epigenetic mechanism by which
valve development may be precisely tailored by blood flow to
create perfectly functioning heart valves, and suggests that small
errors in the transmission of such signals may result in congenital
valve disease.KLF2-GFP quantitation of the areas defined in (D) is shown in (E). Error bars repre
test (n = 4–5 from at least 2 litters).
(F) Schematic depiction of KLF2/KLF4 expression in the endocardium overlying
arrows indicates the relative strength of hemodynamic shear forces.
At, atrium; C, cushion; EC, endocardial cell; LA, left atrium; Mes, mesenchyme;RESULTS
Endocardial KLF2 and KLF4 Are Expressed in a Dynamic
Pattern Predicted byHemodynamic Shear Forces during
Cushion Remodeling
KLF2 expression in endothelial cells is tightly regulated by
fluid shear forces in vitro (Clark et al., 2011; Dekker et al.,
2002; Huddleson et al., 2004; Parmar et al., 2006; Zhou et al.,
2015) and in vivo, where spatial resolution is exquisite, and
significant changes in KLF2 expression have been observed
between adjacent endothelial cells in association with shifting
hemodynamic forces at sites of vascular bifurcation (Clark
et al., 2011; Dekker et al., 2002; Groenendijk et al., 2005; Huddle-
son et al., 2004; Parmar et al., 2006; Zhou et al., 2015). The
related transcription factor KLF4 is less studied in the endothe-
lium, but is also upregulated by fluid shear forces in endothelial
cells in vitro and regulated by the same shear-responsive
MEKK3-ERK5 pathway as KLF2 in endocardial cells in vivo
(Clark et al., 2011; Zhou et al., 2015). Prior studies by us and
others have demonstrated that Klf2 mRNA expression in the
developing heart is endocardial specific and becomes progres-
sively restricted to the endocardial cells overlying the developing
cushions and valves during mid-late gestation (Heckel et al.,
2015; Lee et al., 2006). To further characterize KLF2 expression
in the developing heart, we used anti-GFP antibodies to detect a
GFP-KLF2 fusion protein expressed from the endogenous Klf2
locus (Weinreich et al., 2009). GFP-KLF2 was expressed in the
endothelial cells lining the cardiac cushions after E10.5, but not
in underlying cushion mesenchymal cells (Figure 1A). Quantita-
tive analysis revealed that between E10.5 and E14.5, GFP-KLF2
expression in cushion endocardial cells demonstrated a pro-
gressively graded pattern in which the greatest GFP-KLF2
expression was localized to the central part of the developing
cushions, the site at which blood flows through the narrowest
channel and shear forces are predicted to be highest (Figures
1A–1E). A small amount of GFP-KLF2 expression was also
detected in ventricular endocardial cells, particularly those at
the trabecular tips that are also predicted to be exposed to shear
forces, but ventricular GFP-KLF2 expression was extinguished
by E14.5 (Figure S1A).
We and others have demonstrated that expression of the
KLF2-related transcription factor KLF4 is also upregulated by
fluid shear forces in endothelial cells in vitro and activated by
the same upstream MAPK pathway as KLF2 in endothelial cells
in vivo (Clark et al., 2011; Zhou et al., 2015). Anti-KLF4 antibody
staining revealed that KLF4 expression mirrored that of KLF2,
i.e., was specific to the endothelial cells lining the cardiac
cushions and distributed in a graded manner consistent with
predicted shear forces (Figure 1A). These studies demonstrate
that KLF2 and KLF4 are expressed in a highly graded fashion
in endothelial cells lining the cardiac cushions (Figure 1F), and
suggest that they may function in transducing endothelial cellsent ±SEM, *p% 0.05, ****p% 0.0001 using an unpaired two-tailed Student’s t
the developing AV valve between E10.5 and E14.5. The thickness of the red
OFT, outflow tract; PA, pulmonary artery. See also Figure S1.
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Figure 2. Endocardial Loss of Klf2 Results in Cardiac Cushion Defects and Abnormal Intracardiac Blood Flow
(A) H&E staining of cardiac cushions in Nfatc1Cre/+; Klf2fl/fl and littermate control hearts between E12.5 and E14.5. Scale bar represents 100 mm.
(B) Quantitation of AV cushion volume in E12.5–E14.5Nfatc1Cre/+; Klf2fl/flmice compared with controls. Error bars represent ±SEM, *p% 0.05, **p% 0.01, ***p%
0.001 using an unpaired two-tailed Student’s t test (n = 3–7 from 3 to 4 litters).
(C) Optical tomography 2D X-axis images of E12.5 Nfatc1Cre/+; Klf2fl/fl hearts compared with controls. Red and green structures represent the atrioventricular
cushion and ventricular myocardium, respectively. Scale bar represents 200 mm.
(D) H&E images demonstrating the presence of DORV in Nfatc1Cre/+; Klf2fl/fl mice. Dotted lines denote the path of blood flow from the ventricle to the aorta in
control and Nfatc1Cre/+; Klf2fl/fl animals. Scale bar represents 500 mm.
(E) H&E staining of the membranous septum in E14.5 control and Nfatc1Cre/+; Klf2fl/fl animals. Arrow indicates a septal defect in a Nfatc1Cre/+; Klf2fl/fl heart. Scale
bar represents 100 mm.
(F) Color Doppler of E12.5 control and Nfatc1Cre/+; Klf2fl/fl littermates. Yellow arrows indicate the direction of blood flow. Solid white lines outline the fetal heart.
Scale bar represents 500 mm.
A, aorta; AV, atrioventricular cushion; IVS, interventricular septum; LV, left ventricle; PA, pulmonary artery; PE, pericardial edema; RV, right ventricle. See also
Figures S1 and S2; Movies S1, S2, S3, and S4; Table S1.
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cushions to mature heart valves.
Klf2 Is Required in the Endocardium for Cushion
Remodeling during Heart Valve Development
To functionally test the role of KLF2 specifically in the developing
heart, we used an Nfatc1-Cre allele that expresses Cre
recombinase in the endocardium of the heart but not in the pe-
ripheral vascular endothelium (Wu et al., 2012). Intercrossing
Nfatc1Cre/+; Klf2fl/+ and Klf2fl/fl animals revealed no Nfatc1Cre/+;
Klf2fl/fl (Nfatc1 Klf2 KO) animals at birth, and timed matings
demonstrated embryonic loss of most Nfatc1 Klf2 KO animals4 Developmental Cell 43, 1–16, November 6, 2017by E14.5 (Table S1). Analysis of Nfatc1 Klf2 KO embryo hearts
revealed significant defects in AV and OFT cushion remodeling,
whilemyocardial growth appeared normal until the onset of heart
failure, when the ventricular wall exhibited significant thinning
(Figures 2 and S1B). Cardiac cushions were histologically indis-
tinguishable from those in control embryos until E12.5, when
Nfatc1 Klf2 KO AV and OFT cushions exhibited notably larger
volumes than those in control littermates (Figures 2A–2C). Nfatc1
Klf2 KO cushions also failed to thin and elongate in the direction
of flow in a manner similar to control cushions (Figure 2A).
Early in cardiac development (prior to E14.5 in the mouse),
both the aortic and pulmonic outflow tracts arise from the right
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creates a separate aortic outflow tract from the left ventricle
(Lin et al., 2012). Consistent with a failure of cushion remodeling,
the aortic OFT of E14.5 Nfatc1 Klf2 KO hearts failed to connect to
the left ventricle (thus maintaining a double outlet right ventricle
[DORV]) (Figure 2D), and all Nfatc1 Klf2 KO animals surviving
to E14.5 exhibited a membranous septal defect (Figure 2E;
Movies S1 and S2).
The observed defects in cushion remodeling suggested that
Nfatc1 Klf2 KO embryos die in mid-gestation due to failure of
the developing valves to support the requirement for increasing
blood flow in the embryo. We have previously demonstrated that
embryos lacking Klf2 in all endothelial cells (Tie2 Klf2 KOs)
exhibit increased systolic stroke volumes and death due to
high output heart failure (Lee et al., 2006). These findings were
attributed to abnormal blood vessel tone because lethality was
rescued by alpha adrenergic agonists that act selectively on
peripheral vascular smooth muscle in adult animals. However,
high output heart failure may also arise due to defective heart
valves, and alpha adrenergic rescue may be explained by the
transient expression of alpha adrenergic receptors in embryonic
myocardial cells (Lin et al., 1992). Doppler analysis at E12.5 re-
vealed augmented ventricular outflow in Nfatc1 Klf2 KO hearts
compared with controls (Figure 2F; Movies S3 and S4), findings
consistent with high cardiac output. These observations suggest
that the defective cushion remodeling observed in mid-gestation
Nfatc1 Klf2 KO embryos is associated with abnormal valve func-
tion and hemodynamic changes, resulting in embryonic lethality
due to heart failure.
Although KLF4 is expressed in the cushion endocardium in a
pattern similar to KLF2 (Figure 1A), mice lacking KLF4 survive
to birth with no apparent cardiovascular defects (Segre et al.,
1999), and a role for KLF4 in heart development has not been
defined. To test whether KLF2 and KLF4 play overlapping roles
during heart valve development, we generated mice with endo-
cardial-specific deletion of both alleles of Klf4 and one allele of
Klf2. Nfatc1Cre/+; Klf2fl/+; Klf4fl/fl mice exhibited mid-gestation
lethality associated with cushion defects, DORV, and membra-
nous septal defects identical to those observed in Nfatc1 Klf2
KO embryos (Figure S2). These studies demonstrate that
the shear-regulated transcription factors KLF2 and KLF4 are
expressed in the endothelial cells lining the cardiac cushions in
amanner proportional to predicted shear forces, and play essen-
tial roles in the remodeling processes required for valve and
outflow tract development in the heart.
Klf2 Is Required in Cushion Endocardium and Not
Mesenchyme during Remodeling
Since the Nfatc1-Cre allele drives gene deletion prior to EMT
(Wu et al., 2012), it is possible that the mesenchymal defects
observed in Nfatc1 Klf2 KO embryos reflect a requirement for
KLF2 in mesenchymal rather than endocardial cells. To test the
requirement for KLF2 in cushion mesenchymal cells, we gener-
ated Dermo1Cre/+; Klf2fl/fl (Dermo1 Klf2 KO) animals in which
KLF2 was deleted immediately after the onset of EMT and
expression of Dermo1 (aka Twist2). Analysis of Dermo1-Cre;
R26-loxSTOPlox-YFP animals between E10.5 and E14.5
revealed evidence of Cre recombination in almost all mesen-
chymal cells within the cardiac cushions but not in endocardialcells (Figure 3A). Dermo1 Klf2 KO animals survived to birth
(Table S1) and exhibited no cushion remodeling defects (Fig-
ure 3B), indicating that the defects in Nfatc1 Klf2 KO cardiac
cushions arise due to loss of Klf2 in endocardial and not mesen-
chymal cells.
To further investigate the endocardial role of Klf2 specifically
during cushion remodeling, we examined mice in which Klf2
was deleted by an Nfatc1-enhancer Cre transgene that has
been reported to be active exclusively in the cushion endocar-
dium following cessation of EMT (Wu et al., 2011; Zhou et al.,
2005). Consistent with these studies, R26-loxSTOPlox-YFP
(Figure 3C) and R26-loxSTOPlox-LacZ (Figure 3D) reporter anal-
ysis demonstrated that the Nfatc1-enhancer Cre transgene
drives recombination specifically within the AV and OFT valve
endocardium with no detectable mesenchymal cell recombina-
tion. However, micewith Nfatc1-enhancer Cre-mediated recom-
bination in cushion endothelial cells (Nfatc1en Klf2 KOmice) were
not observed after birth (Table S1), and analysis of E15.5 and
E17.5 Nfatc1en Klf2 KO OFT cushions revealed enlarged OFT
cushions like those observed in Nfatc1 Klf2 KO animals (Fig-
ure 3E). No defects were detected in the AV cushions of Nfatc1en
Klf2 KO mice, most likely due to the less penetrant activity of the
Nfatc1-enhancer Cre at that site and the fact that the
mesenchymal effects of endocardial Klf2 function are cell non-
autonomous. These findings establish that Klf2 is required
specifically in endocardial cells and not in mesenchymal cells
for the normal remodeling of cushions to mature valves.
Endocardial Klf2 Regulates Mesenchymal Cell
Proliferation and Condensation in the Remodeling
Cardiac Cushion
The cellular events associated with cushion remodeling are
primarily mesenchymal and include a slowing of mesenchymal
proliferation after EMT and the condensation of mesenchymal
cells in the region immediately beneath the endocardium to
create a thin and mature valve leaflet (Combs and Yutzey,
2009; Kruithof et al., 2007; Person et al., 2005). Analysis of cell
proliferation following a bromodeoxyuridine (BrdU) pulse re-
vealed a dramatic decrease in mesenchymal cell proliferation
from approximately 40% BrdU+ cells at E11.5 to just over 10%
at E14.5 in control cushions (Figures 4A and 4B). Mesenchymal
cell proliferation in Nfatc1 Klf2 KO cushions was indistinguish-
able from that in control cushions at E11.5 but thereafter
dropped at approximately half the rate observed in control cush-
ions (Figures 4A and 4B). Endocardial cell proliferation remained
unchanged (Figure 4C), and no difference in cellular apoptosis
was observed (Figure S3). Notably, the increase in mesenchymal
cell proliferation in Nfatc1 Klf2 KO cushions was observed
throughout the cushion and not restricted to mesenchymal cells
adjacent to the overlying endocardium (Figure 4A).
Mesenchymal cell condensation is a process in which the
mesenchymal cells in the region just below the endocardium of
the remodeling cushion increase in density (Kruithof et al.,
2007). Analysis of H&E- and DAPI-stained sections revealed a
significant loss of sub-endocardial mesenchymal cell condensa-
tion in Nfatc1 Klf2 KO cushions compared with controls (Figures
4D and 4E). To quantitate mesenchymal cell condensation, we
measured the number of mesenchymal cell nuclei within 50,
100. and 150 mm of the endocardial cell layer. At E11.5, thereDevelopmental Cell 43, 1–16, November 6, 2017 5
Figure 3. Cushion Mesenchymal Cell Defects following Endocardial Klf2 Loss Are Cell Non-autonomous
(A) Lineage tracing of Dermo1-Cre; R26RYFP cells (green) in the embryonic heart from E10.5 to E13.5. DAPI (blue) stains all nuclei. Scale bar represents 100 mm.
(B) H&E staining of cardiac OFT and AV cushions in Dermo1Cre/+; Klf2fl/fl and littermate control hearts at E14.5. Scale bar represents 100 mm.
(C) Lineage tracing of Nfatc1enCre/+; R26REYFP mice in the hearts of E12.5 mice. White arrows indicate endocardial cells devoid of reporter activity lining the
AV cushion. Scale bar represents 100 mm.
(D) Lineage tracing of Nfatc1enCre/+; R26RLacZ mice in the hearts of E16.5 mice. Black arrows indicate endocardial cells devoid of reporter activity lining the
AV valve leaflets. Scale bar represents 100 mm.
(E) H&E staining of OFT and AV valves from E15.5 and E17.5 Nfatc1enCre/+;Klf2fl/fl and littermate controls. Note the enlarged pulmonic and aortic valve cushions
compared with controls. Scale bar represents 200 mm.
A, aorta; AoV, aortic valve; C, cushion; IVS, interventricular septum; LA, left atrium;MV, mitral valve; PA, pulmonary artery; PuV, pulmonary valve; RA, right atrium.
See also Table S1.
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Nfatc1 Klf2 KO or control cushions (Figure 4F). By E12.5, a sig-
nificant increase in the density of mesenchymal cell nuclei was
evident in the region closest to the endocardium (0–50 mm) of
control littermate cushions but not in Nfatc1 Klf2 KO cushions
(Figure 4G). By E13.5, a small amount of mesenchymal conden-
sation was observed in Nfatc1 Klf2 KO cushions, but this
remained significantly less than that in control littermates
(Figures 4D, 4E, and 4H). Similar changes in mesenchymal cell
proliferation and condensation were observed in the developing
valves of Nfatc1Cre/+; Klf2fl/+; Klf4fl/fl mice (Figures S2A–S2C).
These findings identify persistent mesenchymal cell proliferation
and impaired mesenchymal cell condensation as the major cell6 Developmental Cell 43, 1–16, November 6, 2017non-autonomous phenotypes associated with the defective
cushion remodeling conferred by loss of endocardial Klf2
and Klf4.
Endocardial Klf2 Deficiency Results in Loss of
Endocardial Wnt9b Expression and Reduced Canonical
WNT Signaling in Neighboring Mesenchymal Cells
Since KLF2 expression and function are restricted to endocardial
cells, the changes in mesenchymal cell proliferation and
condensation observed in Nfatc1 Klf2 KO animals must reflect
the loss of KLF2-dependent paracrine signals by which the
endocardium instructs underlying mesenchymal cells during
valve development. To identify such signals, Nfatc1 Klf2 KO
Figure 4. Endocardial Loss of Klf2 Results in Altered Mesenchymal Cell Proliferation and Condensation in the Cardiac Cushion
(A) Immunostaining to detect BrdU+ cells (red) in Nfatc1Cre/+; Klf2fl/fl and littermate control hearts at E12.5–E14.5. MF20 (green) marks heart muscle and DAPI
(blue) denotes cell nuclei.
(B and C) Quantitation of BrdU+ mesenchymal (B) and endocardial (C) cells in the AV cushion of E11.5–E14.5 control and Nfatc1Cre/+; Klf2fl/fl littermates. Error
bars represent ±SEM. *p% 0.05, **p% 0.01 using an unpaired two-tailed Student’s t test (n = 3–4 from at least 2 litters).
(D) H&E staining ofNfatc1Cre/+; Klf2fl/fl and control AV cushions at E13.5. Highmagnification images of thewhite boxed regions are shown on the right. The bracket
indicates the region of mesenchymal cell condensation in control cushions at this time point.
(legend continued on next page)
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embryos and analyzed by RNA sequencing (RNA-seq) to identify
KLF2-regulated genes. Analysis of cushion gene expression re-
vealed a nearly complete loss of Wnt9b and markedly reduced
levels of the known canonical WNT target genes Axin2 and
Lef1, as well as the WNT inhibitory proteins Notum and Apcdd1
(Figures 5A–5C and S5). A complex and dynamic pattern of
expression of WNT ligands has been reported in developing
heart valves (Alfieri et al., 2010), and reporters have shown abun-
dant canonical WNT activity in the remodeling cushion (Bosada
et al., 2016; Gitler et al., 2003) as well as in abluminal cells adja-
cent to the endothelial cells lining the site of valve development
in the zebrafish heart (Pestel et al., 2016), suggesting that WNT
signaling may play an important role in this process. However,
the precise role played by WNTs in the remodeling of cushions
tomature valves and themechanisms that regulateWNT expres-
sion in the remodeling cushion have not been defined.
In situ hybridization studies revealed that Wnt9b mRNA
expression was restricted to the endocardiumwith no detectable
Wnt9b in cushion mesenchymal cells at E12.5 (Figure 5D). As
observed for KLF2 and KLF4, Wnt9b expression exhibited a
graded pattern along the cushion endocardium with peak
expression in endothelial cells at the site of close cushion appo-
sition, where shear forces are predicted to be the highest (Figures
5D and 5E). In situ hybridization studies confirmed that Wnt9b
expression was almost abolished in the Nfatc1 Klf2 KO cushion
(Figure 5E). To determinewhether loss of endocardial KLF2 alters
canonical WNT signaling during cushion remodeling, we crossed
Nfatc1 Klf2 KO animals onto an Axin2CreERT2tdTomato reporter in
which expression of Axin2, a highly characterized and ubiquitous
downstream target of canonical WNT signaling (Jho et al., 2002),
is marked by expression of the tdTomato protein (Choi et al.,
2013). In E12.5 control cushions, canonical WNT signaling was
detected exclusively in mesenchymal cells and was notably ab-
sent in endocardial cells (Figure 5F). Although canonical WNT
signaling was present in both mesenchymal cells adjacent to
the endocardium and those deeper within the cushion, it was
strongest in the mesenchymal cells adjacent to the endocardium
(Figure 5F). Nfatc1 Klf2 KO cushions exhibited a marked reduc-
tion of canonical WNT reporter activity throughout the cushion
mesenchyme, consistent with endocardial KLF2 regulation of
mesenchymal cell WNT signaling (Figure 5F). The persistence
of some Axin2 reporter expression suggests that other signals,
derived from either the endocardium or mesenchyme, also regu-
late canonical WNT signaling in the remodeling cushion.
To testwhetherKLF2and/orKLF4 is sufficient to induceexpres-
sion of Wnt9b in endothelial cells, we expressed KLF2, KLF4, or
the LacZ gene in human microvascular endothelial cells and
measured the expression ofWNT9B and the knownKLF2/4 target
geneNOS3byqPCR (Figure 5G). BothWNT9B andNOS3 expres-
sion were highly induced in response to KLF2 and KLF4 expres-
sion (Figure 5G), consistent with a cell autonomous mechanism
in which KLF2 and KLF4 drive endocardial expression ofWnt9b.(E) Mesenchymal cell condensation in the indicated AV cushions was calculated b
at the indicated distances (yellow brackets) from the endocardium. High magnifi
(F–H) Quantitation of mesenchymal condensation at varying distances from the e
E11.5, E12.5, and E13.5. Error bars represent ±SEM, *p% 0.05 using an unpaire
E, endocardium; IVS, interventricular septum; LA, left atrium; M, mesenchyme. A
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lack of any change in Nfatc1, a gene expressed by endocardial
cells that is known to play a critical role in cushion remodeling
similar to that observed for KLF2 (Chang et al., 2004), and a
lack of change in expression of Trpv4, Pkd2 (Trpp2), or Fn1 (Fig-
ure S5), genes previously associated with klf2a function in the
developing zebrafish heart valve (Heckel et al., 2015; Steed
et al., 2016). To further investigate potential regulation of
NFATC1 by KLF2, we stained Nfatc1 Klf2 KO and control cush-
ionswith anti-NFATC1 antibodies. Nuclear NFATC1 staining was
not reduced in KLF2-deficient endocardial cells of the OFT and
AV cushions at E13.5 (Figure S4A), suggesting that the calci-
neurin/NFATC1 pathway is not downstream of KLF2 during valve
development. In addition, overexpression of NFATC1 in
HMVECs did not result in a significant change inWNT9B expres-
sion (Figure S4B), demonstrating a highly specific regulation of
WNT9B by KLF2.
Loss of Endocardial Wnt9b Results in Defects in
Mesenchymal Cell Proliferation and Condensation
Identical to Those Observed with Loss of
Endocardial Klf2
The studies described above suggested that loss of canonical
WNT signaling in mesenchymal cells is the major molecular ab-
normality in Nfatc1 Klf2 KO cushions, and that WNT9B might
be the endocardial WNT ligand primarily responsible for this
defect. WNT9B signaling through both canonical and non-
canonical pathways is required for kidney development (Carroll
et al., 2005; Karner et al., 2009), but cardiac defects have not
been previously described. Analysis of E14.5 embryos from
Wnt9b+/ intercrosses generated on a mixed strain background
revealed enlarged cardiac cushions in approximately 50% of
Wnt9b/ embryos and septal cushion defects in 100% of
Wnt9b/ embryos, although DORV was not observed (Figures
S6A–S6C). Significantly, analysis of cushion mesenchymal cells
revealed loss of condensation and increased proliferation like
that observed in Nfatc1 Klf2 KO animals (Figures S6D–S6F).
Although our studies (Figures 5D and 5E) and those of others
(Alfieri et al., 2010) reveal a highly specific pattern of Wnt9b
expression in the endocardial cells that overlie the remodeling
cardiac cushions, it is possible that global loss of Wnt9b alters
cushion remodeling indirectly, e.g., through compromised fetal
viability or altered hemodynamics associated with renal agen-
esis or due to an unexpected cell autonomous requirement in
mesenchymal cells. To test the role of Wnt9b specifically in the
heart, we generated Nfatc1 Wnt9b KO and Dermo1 Wnt9b KO
animals in which loss ofWnt9b is restricted to endocardial cells
and endocardial-derived mesenchymal cells or only mesen-
chymal cells, respectively. The majority of Nfatc1 Wnt9b KO
animals died prior to birth (Table S1) and exhibited identical
defects in cushion size (Figures 6A and 6B), mesenchymal but
not endocardial cell proliferation, and condensation
(Figures 6C–6G) to those observed in Wnt9b/ and Nfatc1y measuring the number of mesenchymal cell nuclei (DAPI, white) per unit area
cation images of the white boxed regions are shown on the right.
ndocardium in AV cushions from Nfatc1Cre/+; Klf2fl/fl and littermate controls at
d 2-tailed Student’s t test (n = 3 from at least 2 litters).
ll scale bars represent 100 mm. See also Figures S2 and S3.
Figure 5. KLF2 Regulates Endocardial Wnt9b Expression and Canonical WNT Signaling in Mesenchymal Cells of the Developing Valve
(A) Differential gene expression between E12.5 AV cushions from Klf2fl/fl mice and Nfatc1Cre/+; Klf2fl/fl mice was determined using RNA-seq analysis. Heatmap
displays the top 20 differentially expressed genes with p% 0.05 and false discovery rate%0.1. Red stars indicate known Wnt signaling genes. Each replicate
consists of 6 AV cushions combined from 6 different litters.
(B) Gene ontology analysis of all significant differentially expressed genes between Klf2fl/fl and Nfatc1Cre/+; Klf2fl/fl cushions.
(C) qPCRmeasurement ofWnt target gene expression from the indicated E12.5 hearts. Error bars represent ±SEM, *p% 0.05, **p% 0.01, ****p% 0.0001 using an
unpaired two-tailed Student’s t test (n = 3–4 from at least 3 litters).
(D) In situ hybridization for Wnt9b (red) in developing control OFT and AV valves between E10.5 and E13.5. DAPI (blue) staining denotes nuclei. Scale bar
represents 100 mm.
(E) In situ hybridization forWnt9b (red) in developingNfatc1Cre/+; Klf2fl/fl and control valves at E13.5. DAPI (blue) staining denotes nuclei. Scale bar represents 100mm.
(F) Axin2CreERT2-tdTomato reporter activity is detected in the indicated developing heart valves using anti-RFP immunostaining (red). Endocardial cells are identified
using anti-PECAM staining (green). High magnification images from boxed regions are shown on the right. Scale bars represent 100mm.
(G) qPCR ofWNT9B and NOS3 gene expression in HMVECs following exposure to adenoviral vectors encoding LacZ or KLF2 and/or KLF4 for 24 hr. Error bars
represent ±SEM, ***p% 0.001 using an unpaired two-tailed Student’s t test (n = 3).
A, aorta; C, cushion; LA, left atrium; PA, pulmonary artery. See also Figures S4 and S5.
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exhibited normal survival and heart valve development (Table
S1 and Figure 6H), consistent with an endocardial-specific
requirement for Wnt9b. Unlike Wnt9b/ animals, the cardiac
defects in Nfatc1 Wn9b KO animals were almost fully penetrant,
most likely reflecting the effect of background strain, a factor
previously reported to influence the phenotype of KLF2-deficient
embryos (Chiplunkar et al., 2013). These studies reveal that
endocardial KLF2 and WNT9B regulate the same mesenchymal
cell responses required for cushion remodeling to mature
valves and suggest that KLF2-WNT9B signaling is a primary
signaling pathway by which the endocardium regulates heart
valve development.
wnt9bExpression Is Endocardial Specific andRegulated
by Hemodynamic Forces in the Developing
Zebrafish Heart
The studies described above support a model in which hemody-
namic forces regulate heart valve development through dynamic
endocardial KLF2-WNT9B signaling that instructs underlying
mesenchymal cells (Figure S7). However, a direct link between
KLF2-WNT9B signaling and hemodynamic forces during this
process cannot be tested in the mouse because interruption of
blood flow results in lethality prior to cushion remodeling and
mature valve formation (Wakimoto et al., 2000). To test the role
of hemodynamic forces in this pathway, we next examined
the expression of wnt9b in zebrafish embryos that are viable
without blood flow beyond the time point of heart valve develop-
ment and in which klf2a has been shown to play a requisite role in
heart valve development downstream of hemodynamic shear
forces (Vermot et al., 2009). Whole-mount in situ hybridization
for wnt9b revealed highly specific expression at the site of the
developing AV valve and the outflow tract in the 48 hpf fish heart
(Figure 7A), a result that mirrored mouse Wnt9b expression
(Figures 5D and 5E). To more precisely localize the cellular
source of wnt9b expression in the developing zebrafish heart,
we performed in situ hybridization with RNAscope probes that
permit simultaneous detection of wnt9b and klf2a mRNAs on
histologic sections (Wang et al., 2012). As previously observed
for klf2a (Vermot et al., 2009), wnt9b was highly specifically
expressed in endocardial cells lining the site of the developing
AV valve and the cardiac OFT (Figures 7B and 7C). Moreover,
confocal analysis demonstrated co-expression of wnt9b and
klf2a by individual endocardial cells at these sites (Figures 7B
and 7C). Prior studies have demonstrated that klf2a expressionFigure 6. Endocardial Loss ofWnt9b Confers Valve Defects Like Thos
(A) H&E staining of developing AV and OFT valves in E13.5 and E14.5 Nfatc1Cre/
(B) Quantitation of AV cushion volumes from Nfatc1Cre/+; Wnt9bfl/flmice and litterm
an unpaired two-tailed Student’s t test (n = 4 from 3 litters).
(C) Immunostaining to detect BrdU+ cells (red) in Nfatc1Cre/+; Wnt9bfl/fl and litterm
denotes cell nuclei.
(D and E) Quantitation of BrdU+ mesenchymal (D) and endocardial (E) cells in the
Error bars represent ±SEM, ****p% 0.0001 using and unpaired two-tailed Stude
(F) Mesenchymal cell condensation in E14.5 AV cushions was calculated by mea
indicated distances (yellow brackets) from the endocardium. Images on the righ
(G) Quantitation of mesenchymal condensation at varying distances from the A
littermate controls. Error bars represent ±SEM, *p% 0.05, **p% 0.01 using an u
(H) H&E staining of cardiac OFT and AV cushions in Dermo1Cre/+; Wnt9bfl/fl and l
A, aorta; LA, left atria; PA, pulmonary artery. All scale bars represent 100 mm. Sein the endocardial cells overlying the developing AV valve is
strictly dependent upon blood flow and hemodynamic shear
forces (Heckel et al., 2015; Steed et al., 2016; Vermot et al.,
2009). As previously shown for klf2a, wnt9b expression was
extinguished or severely reduced in the hearts of silent heart
(tnnt2a) mutant fish that lack blood flow (Sehnert et al., 2002)
(Figures 7D and 7E).wnt9b expression was also lost in the hearts
of gata1 mutant fish that maintain normal blood flow but experi-
ence reduced vascular shear forces due to anemia and low
blood viscosity (Figures 7D and 7E). Finally, wnt9b expression
was markedly reduced in fish hearts lacking klf2a (Figures 7D
and 7E). These studies reveal a highly specific and conserved
pattern of expression for klf2a andwnt9b in the endocardial cells
that overlie the developing heart valve, and establish that
endocardial KLF2-WNT9B signaling is strictly regulated by
hemodynamic shear forces during heart valve development.
DISCUSSION
Physical forces generated by flowing blood have long been
proposed to instruct development of the heart, and of heart
valves in particular (Hogers et al., 1999; Hove et al., 2003;
Sedmera et al., 1999; Vermot et al., 2009; Yalcin et al., 2010;
Steed et al., 2016). However, many of the cellular processes
proposed to be regulated by hemodynamic forces during heart
valve development take place away from the flowing blood,
especially sub-endocardial mesenchymal cell remodeling by
which cardiac cushions are remodeled to mature valves. How
hemodynamic forces are converted to molecular instructions
that are relayed across the endothelium to control such cellular
behavior during heart valve development has been unknown.
In the present study, we use mouse and zebrafish studies to
identify WNT9B as an essential paracrine effector of endocardial
KLF2 that is tightly regulated by hemodynamic forces during
heart valve development. The KLF2-WNT9B signaling axis is a
conserved mechanism by which fluid shear forces experienced
by endothelial cells are converted to molecular instructions
that direct cells deep within the developing heart valve (Fig-
ure S7). These findings reveal a specific molecular mechanism
by which cardiovascular forces generated by the beating heart
feed back to control its development and suggest that subtle
disturbances in this highly precise chain of communication
may underlie common valvular congenital defects.
A key link established by these studies is that between the
expression of KLF2/4 and WNT9B in the endothelial cells thate Observed with Endocardial Loss of Klf2
+; Wnt9bfl/fl and control hearts.
ate controls at E14.5. Error bars represent ±SEM, *p% 0.05, **p% 0.01 using
ate control hearts at E14.5. MF20 (green) marks heart muscle and DAPI (blue)
AV cushions of E14.5 Nfatc1Cre/+; Wnt9bfl/fl and littermate controls is shown.
nt’s t test (n = 3–5 from at least 2 litters).
suring the number of mesenchymal cell nuclei (DAPI, white) in a given area at
t are higher magnification images of the white boxed regions.
V cushion endocardium in E14.5 Nfatc1Cre/+; Wnt9bfl/fl hearts compared with
npaired two-tailed Student’s t test (n = 3–6 from at least 2 litters).
ittermate control hearts at E14.5.
e also Figure S6 and Table S1.
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Figure 7. wnt9b Expression in the Developing Zebrafish Heart Is Regulated by Hemodynamic Shear Forces
(A) Whole-mount in situ hybridization for wnt9b in 48 hpf wild-type zebrafish embryos. Dotted lines outline the heart. Scale bars: top, 0.1 mm; bottom, 0.03 mm.
(B and C) In situ hybridization using RNAscope for klf2a andwnt9b in 48 hpf and 56 hpf wild-type zebrafish embryos is shown using merged z stack (B) and single
slice (C) confocal analysis. Scale bar represents 100 mm and 10 mm for the magnified images in (B).
(D) In situ hybridization to detectwnt9b expression in the developing AV cushion and outflow tract of 48 hpf wild-type fish (control), silent heart (tnnt2a/) mutants
that lack blood flow, gata1 mutants (gata1/) that experience low shear stress due to low blood viscosity, and klf2a mutants (klf2a/) is shown. Dotted lines
outline the heart. Scale bars: left, 0.2 mm; right, 0.06 mm.
(E) The percentage of embryos in which wnt9b expression is normal, absent, or mis-expressed in the AV cushion or OFT is shown. The n for each group is
indicated in (D). ****p < 0.0001 using chi-squared analysis.
A, atrium; AV, atrioventricular; OFT, outflow tract; V, ventricle.
12 Developmental Cell 43, 1–16, November 6, 2017
Please cite this article in press as: Goddard et al., Hemodynamic Forces Sculpt Developing Heart Valves through a KLF2-WNT9B Paracrine Signaling
Axis, Developmental Cell (2017), https://doi.org/10.1016/j.devcel.2017.09.023
Please cite this article in press as: Goddard et al., Hemodynamic Forces Sculpt Developing Heart Valves through a KLF2-WNT9B Paracrine Signaling
Axis, Developmental Cell (2017), https://doi.org/10.1016/j.devcel.2017.09.023overlie the developing heart valves. Seminal studies in zebrafish
embryos have established that heart valves fail to form when
blood flow through the heart is mechanically blocked (Hove
et al., 2003) and have identified endocardial klf2a as a critical
effector of fluid shear forces in the developing valve, the expres-
sion of which changes rapidly and coordinately with maneuvers
that alter hemodynamic forces (Heckel et al., 2015; Renz et al.,
2015; Steed et al., 2016; Vermot et al., 2009). These findings
are consistent with the identification of Klf2 as a gene regulated
by fluid shear in studies of cultured human endothelial cells
(Clark et al., 2011; Dekker et al., 2002; Huddleson et al., 2004;
Parmar et al., 2006; Zhou et al., 2015), with the observation
that endocardial KLF2 expression is similarly altered by changes
in blood flow in the embryonic chicken heart (Groenendijk et al.,
2005), with the fact that KLF2 expression in both the mouse and
human cardiovascular systems follows predicted shear forces
with remarkable cellular resolution (Clark et al., 2011; Dekker
et al., 2002; Huddleson et al., 2004; Parmar et al., 2006; Zhou
et al., 2015), and with the observation that endocardial KLF2 is
expressed in a graded manner predicted by exposure to shear
forces in developing valves (Figures 1A–1E) (Lee et al., 2006).
Despite this highly conserved association between endothelial
KLF2 expression and hemodynamic shear forces, the key
effectors of KLF2 have remained obscure and its precise role
in coupling fluid shear forces to heart development is unclear.
The identification of Wnt9b as an essential KLF2 effector
downstream of hemodynamic forces in the developing heart
valve fills this gap in knowledge and identifies a clear molecular
mechanism for the conversion of hemodynamic mechanical
forces to biological responses in the heart. Whether hemody-
namic forces and KLF2/4 expression are converted to WNT9B
signals in particular, or WNT signals in general, at other sites in
the cardiovascular system remains an important open question.
The identification of Wnt9b as a critical KLF2 effector ex-
pressed in response to hemodynamic forces in the developing
heart valve is consistent with prior studies of WNT signaling
during vertebrate heart valve development and well-established
molecular aspects of this signaling mechanism. Canonical WNT
signaling has been shown to be required for heart valve develop-
ment in zebrafish embryos (Hurlstone et al., 2003). More recent
studies in the fish have demonstrated that canonical WNT sig-
nals arise specifically in sub-endocardial, abluminal cells, a
finding analogous to the high level of canonical WNT signaling
observed in the sub-endocardial mesenchymal cells of the
remodeling cushion in the developing mouse heart (Figure 5F;
Gitler et al., 2003), and that these WNT signals are dependent
upon hemodynamic forces (Pestel et al., 2016). WNTs are partic-
ularly well suited for a role in converting hemodynamic forces
sensed by endothelial cells to instructions transmitted to suben-
dothelial cells during this remodeling process because WNT
signaling is stringently paracrine (Farin et al., 2016), enabling
differences in hemodynamic shear to drive precisely graduated
signals at single-cell resolution. A large number of WNT ligands
are known to be expressed at distinct time points during heart
valve development (Alfieri et al., 2010), but clearly defining the
roles of WNT signaling during valve development has been
challenging because of potential functional redundancy, the
fact that WNT signaling plays numerous roles at distinct times
and places (e.g., during EMT and later during cushion remodel-ing), and that multiple cell types (i.e., myocardial, mesenchymal,
endocardial) may secrete and/or respond to WNT ligands
(Bosada et al., 2016; Hurlstone et al., 2003; Liebner et al.,
2004). Approaches that broadly inhibit canonical WNT signaling
(e.g., deletion of b-catenin or overexpression of the canonical
pathway inhibitor DKK1; Bosada et al., 2016) have failed to
clearly define the roles of WNT signaling in cushion remodeling,
because early blockade of WNT signaling inhibits EMT and
prevents cushion formation altogether (Hurlstone et al., 2003;
Liebner et al., 2004). Our studies reveal that endocardial Wnt9b
is required to slow mesenchymal cell proliferation and drive the
sub-endocardial mesenchymal cell condensation by which a
bulky cushion is remodeled into a mature valve cusp. While
the effects of Wnt9b on sub-endocardial mesenchymal cell
condensation are likely to be direct, we also observe changes
in mesenchymal cell proliferation deep within the cushion
mesenchyme following loss of endocardial Klf2 or Wnt9b that
most likely reflect disruption of a still undefined chain of signals
initiated by endocardial-mesenchymal cell WNT9B signaling.
These studies confirm the proposed complexity of WNT
signaling during valve development (Bosada et al., 2016; Gessert
and Kuhl, 2010) and highlight the need to study this process in
a highly specific spatiotemporal manner.
Our studies support amodel in which hemodynamic forces are
transduced by endocardial cells through KLF2 and KLF4 that in
turn drive paracrine Wnt9b signals that provide the primary
instructions by which underlying cushion mesenchyme is
sculpted to the mature valve (Figure S7). An attractive aspect
of this model is that it provides an explanation for how control
of heart valve development can be so precisely linked to heart
valve function, i.e., how mature valve leaflets can form such
that they neither impede the forward flow of blood nor permit
its backward flow over a lifetime of constant use. In vitro and
in vivo studies of KLF2 expression in response to fluid shear
have revealed robust responses to both pulsatile and reversing
flow (Dekker et al., 2002; Heckel et al., 2015; Vermot et al.,
2009; Wang et al., 2006). Thus, endocardial cells overlying areas
of the remodeling cushion that either excessively oppose
forward blood flow or permit backward flow will be subject to
higher shear forces and predicted to have higher KLF2/
4-WNT9B expression that in turn drives more aggressive under-
lying cushion remodeling until such stimuli abate. Such a
model predicts that even a minor breakdown in the series of pre-
cisely graded signals required to accurately transduce such
hemodynamic information may result in a subtly defective valve,
providing an epigenetic explanation for common congenital
valve defects that permit survival to birth. Future studies that
more fully define the chain of paracrine signals by which
hemodynamic forces direct heart valve development are likely
to provide additional insight into why heart defects are the
most common congenital abnormality.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Models
Nfatc1Cre (Wu et al., 2012), Nfatc1enCre (Wu et al., 2011), Klf2fl/fl (Lee et al., 2006), Klf2GFP (Weinreich et al., 2009), Axin2CreERT2/tdT
(Choi et al., 2013), Wnt9b-/- (Carroll et al., 2005), Wnt9bfl/fl (Carroll et al., 2005), Klf4fl/fl (Katz et al., 2002), ROSAEYFP (Madisen
et al., 2010) and Dermo1Cre (Sosic et al., 2003) animals have been previously described. For all experiments littermates
lacking Cre were used as controls and all animals were on a mixed background. Embryonic ages for each experiment are indicated
in the figured legends, and embryo genders were unknown at the time of harvest. All animals were housed in a pathogen-free
environment in an AAALAC-approved vivarium at the University of Pennsylvania, and experiments were performed in accordance
with the guidelines of the Committee for Animal Research.
Zebrafish
Zebrafish lines used in this study were Tg(klf2aig4) (Steed et al., 2016), vlad tepesm651 (gata1) (Lyons et al., 2002), and tnnt2atc300b
(Sehnert et al., 2002). All zebrafish experiments were approved by the Animal Experimentation Committee of the Institutional Review
Board of the IGBMC.
Cell Culture
Pooled humanmicrovascular endothelial cells HMVECs (Lonza) were grown in endothelial basal medium supplemented with EGM-2
MV SingleQuots (Lonza). HMVECs were infected overnight with LacZ (Penn Vector Core) KLF2 (Penn Vector Core) KLF4 (Vector
Biolabs), or NFATC1 (Penn Vector Core) adenovirus at an MOI of 5. Forty-eight hours after infection, total RNA was isolated using
TRIzol Reagent (Invitrogen). cDNA was generated from 1 mg total RNA using Superscript III Reverse Transcriptase (Invitrogen).
qPCR was performed in Power SYBR Green PCR Master Mix (Applied Biosciences).
METHOD DETAILS
Histology and Immunohistochemistry
Mouse embryos were fixed in 4% paraformaldehyde(PFA) overnight at 4C, dehydrated to 100% ethanol, and embedded in paraffin.
Sections (7mm thick) were used for immunohistochemistry and haematoxylin and eosin staining. The following antibodies were used
for immunostaining: goat anti-GFP (1:250, AbCam), rat anti-BrdU (1:100, AbCam), mouse anti-MF-20 (1:20, HybridomaBank), rabbit
anti-RFP (1:250, Rockland), anti-KLF4 (1:100, R&D), rat anti-PECAM (1:50; HistoBioTec DIA-310), mouse anti-fibronectin (1:100,
Santa Cruz) and mouse anti-NFATC1 (1:50, BDPharminagen). Images were taken on a Nikon Eclipse 80i fluorescent
microscope (Nikon).
In Situ Hybridization
Probes for mouse Wnt9b in situ hybridization were generated by PCR amplification of kidney cDNA using previously
designed primers (Alfieri et al., 2010). In situ hybridization was done as previously reported (Lee et al., 2006). For zebrafish whole
mount in situ hybridization studies the pUC57 containing full length wnt9b cDNA (NM_001137660) (NovoPro) was used to subclone
the wnt9b cDNA into pGEMt-easy vector using the following primers: forward 5’-TATTGCCCTCTGCATCCTTC-3’ and reverseDevelopmental Cell 43, 1–16.e1–e5, November 6, 2017 e3
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hybridizations were performed as previously described (Thisse and Thisse, 2008). In brief, embryos were placed in 24 well plate
baskets containing 100% methanol then rehydrated to PBST. Permeabilization was achieved using proteinase K (10 mg/mL diluted
in PBST) at room temperature for 30 min, followed by post-fixation in 4% PFA for 20 min. Embryos were then washed in PBST and
then incubated with pre-warmed hybridization mix (50% Formamide, 5% SSC, 50 mg/ml Heparin, 500 mg/ml tRNA, 0.1% Tween-20,
0.92% 1M citric acid pH6 in water) for a minimum of 3 hours at 70C. The hybridization mix was then replaced by 200 mL of
hybridization mix supplemented with 2 ml of wnt9b probe and incubated overnight at 70C. Embryos were washed by successive
washes of 10 min each in MH buffer (50% formamide, 25% 20X SSC, 0.5% Tween-20, 0.92 % Citric acid 1M pH6 in water) 75%
(vol/vol), 50% (vol/vol), 25% (vol/vol) MH buffer in 2X SSC, 100 % 2X SSC and 0.2X SSC for 30 min at 70C. Then samples were
washed in 75% (vol/vol), 50% (vol/vol), 25% (vol/vol) 0.2X SSC in PBST and finally in 100% PBST every 10 min at room temperature.
Embryoswere incubated in 20%blocking solution (Roche) in PBST for 3h at room temperature and then incubated overnight at 4C in
anti-DIG (alkaline phosphatase antibody, 1:10000, Roche) in 20% blocking solution with gentle rocking. The next day, embryos were
washed in PBST at room temperature and placed in revelation solution (10% Tris-HCl 1M pH9.5, 5%MgCl2 1M, 2% NaCl 5M, 0.5%
Tween-20 in water). Revelation was done at room temperature in BM-purple (Sigma). Embryos were washed in PBST several times
and fixed in 4%PFA for storage. For RNAscope analysis, 48 and 56hpf wildtype zebrafish embryos were fixed in 4%PFA overnight at
4C. The fixed embryos were dehydrated to 100% ethanol, embedded in paraffin and cut into 6 mm thick sections. Sections were
stained using the RNAscope Fluorescent Multiplex kit (Advanced Cell Diagnostics).
In Vivo BrdU Incorporation Assay
Pregnant mice were injected intraperitoneally with 10 mg/g BrdU (Sigma) for 1 hour prior to embryo harvest. Paraffin sections were
immunostained with anti-BrdU (1:100; AbCam) antibodies and nuclei visualized with DAPI. Quantitation of BrdU was performed
by dividing the number of BrdU+ cells within a 7 mm AV valve section by the total number of DAPI positive cells in the same section.
BrdU percentages were averaged from multiple AV valve sections per animal.
Cushion Quantitation
To examine KLF2-GFP intensity across the valve, GFP stained sections were converted to 8-bit and a line was drawn along the
endocardium across the distance of the valve. Using ImageJ (NIH), image intensity across this line was then analyzed by generating
a plot profile. To quantify intensity values, valves were divided into three sections, the area of the valve where the endocardiummakes
contact with the neighboring leaflet, and the two areas distal to this region. Gray values per pixel were generated from plot profiles of
several AV sections per animal and were averaged from several analyzed sections. Quantitation of AV valve volume was performed
by measuring the AV valve area of several HE sections and multiplying the sum of these areas by the tissue depth as determined by
tissue section thickness. Quantitation of mesenchymal condensation was performed by counting the number of DAPI+ cells within a
defined distance from the endocardium and dividing this by the cushion area included in this distance. Several AV valve sectionswere
analyzed per animal and averaged.
Fetal Echocardiography
Pregnant mice were lightly anesthetized with 1-2% isoflurane and the uterus was exposed. In utero echocardiography was
performed using a high-resolution micro-ultrasound system (VisualSonic Vevo 2100) with a 40 MHz mechanical transducer
(MS550D). During scanning, maternal body temperature and heart rate were maintained within normal limits.
Optical Projection Tomography
E12.5 embryonic hearts were dissected and fixed overnight in 4% paraformaldehyde. Hearts were then embedded in 1% low-melt
agarose, dehydrated in methanol, and then cleared in 1:2 (v/v) benzyl alcohol and benzyl benzoate as previously described (Sharpe
et al., 2002). Organs were then scanned using the Bioptonics OPT Scanner (3001M) and color overlay of 2D images was done using
Photoshop CS5.1.
Expression Studies
Total RNA was extracted from E12.5 AV cushions using the RNeasy Micro Kit (Qiagen). RNA quantity and quality were assayed with
an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Libraries were prepared using the TruSeq Stranded Total RNA
Library Prep Kit with TruSeq RNA preparation kits with Ribo-Zero ribosomal RNA reduction chemistry (Illumina, San Diego, CA).
100bp single-read sequencing was performed on an Illumina HiSeq2500 sequencer in high output mode. Casava1.8.2 software
was used for base calling (Illumina). GO analysis was performed by entering in the list of significantly changed genes into the
gene ontology consortium (Release 20160715 (Ashburner et al., 2000; Gene Ontology Consortium, 2015)).
Casava1.8.2 software was used for base calling (Illumina). Low quality reads were filtered out as a first step. Next, ribosomal and
repeat sequences were filtered out by alignment to a set of repeat sequences using the bowtie aligner (bowtie version 0.12.7),
allowing 3mismatches. Remaining reads were aligned to themouse reference genome (NCBI build 37, mm9) and to the set of known
transcripts included in RefSeq, UCSC known genes, and ENSEMBL transcripts, using RNA-Seq unified mapper (RUM) alignment
software (University of Pennsylvania School of Medicine, Philadelphia, PA). RUM-computed transcript-, exon-, and intron-level
quantitations of only uniquely aligning reads were used for further analysis.e4 Developmental Cell 43, 1–16.e1–e5, November 6, 2017
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extracted from the RUM output and processed for differential expression analysis. Pair-wise comparisons were carried out using
a custom script implementing the EdgeR software (Walter and Eliza Hall Institute of Medical Research, Parkville, Australia). The
p-values from EdgeR were corrected for multiple testing using the Benjamini & Hochberg mode of the R function p.adjust. Data
was summarized for individual genes by selecting a ‘‘representative transcript’’ with the highest read counts for each gene. Intensity
heatmap was generated using heatmap.2 function of R package gplots. Quantile normalized log2 expression values of genes were
scaled on the mean log2 expression across samples and visualized on a color scale.
For validation of gene expression, total RNA was collected from whole E12.5 embryonic hearts. cDNA was synthesized from
150 ng total RNA using the Superscript III Reverse Transcriptase (Invitrogen). Real-time PCRwas performedwith Power SYBRGreen
PCR Master Mix (Applied Biosciences).
QUANTIFICATION AND STATISTICAL ANALYSIS
3-7 biological replicates were used for all experiments. All data were analyzed with GraphPad Prism (version 7) and represented as
mean ± SEM. p values were calculated using an unpaired 2-tailed Student’s t-test, or chi-square analysis as indicated in the figure
legends. A p value less than 0.05 was considered statistically significant and is denoted as follows: *<0.05, **<0.01, ***<0.001
and ****<0.0001.
DATA AND SOFTWARE AVAILABILITY
The RNA-seq data set has been deposited in the NCBI GEO under accession number GEO: GSE80964.Developmental Cell 43, 1–16.e1–e5, November 6, 2017 e5
